Histopathologic Evaluation and Scoring of Viral Lung Infection
- 28 December 2019
- book chapter
- Published by Springer Nature
- Vol. 2099, 205-220
Abstract
Emergent coronaviruses such as MERS-CoV and SARS-CoV can cause significant morbidity and mortality in infected individuals. Lung infection is a common clinical feature and contributes to disease severity as well as viral transmission. Animal models are often required to study viral infections and therapies, especially during an initial outbreak. Histopathology studies allow for identification of lesions and affected cell types to better understand viral pathogenesis and clarify effective therapies. Use of immunostaining allows detection of presumed viral receptors and viral tropism for cells can be evaluated to correlate with lesions. In the lung, lesions and immunostaining can be qualitatively described to define the cell types, microanatomic location, and type of changes seen. These features are important and necessary, but this approach can have limitations when comparing treatment groups. Semiquantitative and quantitative tissue scores are more rigorous as these provide the ability to statistically compare groups and increase the reproducibility and rigor of the study. This review describes principles, approaches, and resources that can be useful to evaluate coronavirus lung infection, focusing on MER-CoV infection as the principal example.Keywords
This publication has 67 references indexed in Scilit:
- The Invisible Gorilla Strikes AgainPsychological Science, 2013
- The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian HamstersPLOS ONE, 2013
- Pathology is a critical aspect of preclinical aging studiesPathobiology of Aging & Age-related Diseases, 2013
- Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology - a systematic reviewBMC Veterinary Research, 2013
- Successful integration of the histology core laboratory in translational researchJournal of Histotechnology, 2012
- The Use of Immunohistochemistry for Biomarker Assessment—Can It Compete with Other Technologies?Toxicologic Pathology, 2011
- Lung structure phenotype variation in inbred mouse strains revealed through in vivo micro-CT imagingJournal of Applied Physiology, 2010
- Proliferative and Nonproliferative Lesions of the Rat and Mouse Respiratory TractToxicologic Pathology, 2009
- Genetically Programmed Biases in Th1 and Th2 Immune Responses Modulate AtherogenesisThe American Journal of Pathology, 2008
- ‘One medicine—one pathology': are veterinary and human pathology prepared?Laboratory Investigation, 2008